Published in Gene Therapy Weekly, September 18th, 1995
Now scientists at the University of Wisconsin (UW) Medical School appear to have found a way to protect critical human cells from the ravages of chemotherapy. By genetically engineering cellular "waste collectors," they created enzymes capable of disarming a single targeted drug.
"Our plan was to identify a drug-metabolizing enzyme that could efficiently detoxify a specific drug or family of drugs," said William E. Fahl, professor of oncology at the Medical School's McArdle Laboratory for Cancer Research, who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.